Skip to main content

United Arab Emirates · Other

IPR [phone withheld] - SOQ 22602547 - Pharmaceutical Item / SSS

Dubai Academic Health Corporation

Active

Tender summary

The Dubai Academic Health Corporation is seeking bids for 300 units of RISANKIZUMAB 360 MG/2.4 ML (150 MG/ML) subcutaneous wearable injectors. Bidders must enter unit prices without VAT, which will be added at the PO stage if applicable. The deadline for submissions is 26 October 2026 at 10:00 local time (Asia/Dubai).

Tender Overview

This tender, reference tender_243681, is issued by the Dubai Academic Health Corporation in AE, categorized as Other.

Scope of Supply

The tender is for a Pharmaceutical Item / SSS, specifically 300 EA of RISANKIZUMAB 360 MG/2.4 ML (150 MG/ML) SUBCUTANEOUS WEARABLE INJECTOR.

Submission Requirements

Unit prices or item values must be entered WITHOUT VAT, with the VAT category selected for each item quoted. If VAT is applied, it will be added at the PO stage; contact the Federal Tax Authority for clarifications.

The response currency is AED.

Important Dates

  • Opportunity Publication Date: 21 October 2026 at 13:00.
  • Closing date/time: 26 October 2026 at 10:00 Asia/Dubai.
Buyer
Dubai Academic Health Corporation
Country
United Arab Emirates
Category
Other
Closing date
26 October 2026
Updated
23 October 2026